Abstract:Gaurav Kaushik, 1, 2 Richa Vashishtha, 2 Chaitenya Verma, 3 Shipra Sharma, 4 Vinay Kumar 5 1 School of Allied Health Sciences, Sharda University, Greater Noida, Uttar Pradesh, 201310, India; 2 Department of Medicine, All India Institute of Medical Sciences, New Delhi, 110029, India; 3 Department of Pathology, Wexner Medical Center, Ohio State University, Columbus, OH, USA; 4 Shri Guru Ram Rai Institute of Medical & Health Sciences, Dehradun, Uttarakhand, 248001, India; 5 Pennsylvania State University Hershey Medical Center, 500 University Dr, Hershey, PA, 17033, USA Correspondence: Gaurav Kaushik; Vinay Kumar, Email ; Background: Toll-like receptors (TLRs) are identified as one of the key components of the innate immune system. The objective of this study was to explore the influence of genetic variability in these TLRs on human immunodeficiency virus (HIV) disease progression with and without tuberculosis (TB) co-infection. Materials and Methods: This prospective, cross-sectional, and longitudinal study included 373 HIV-positive patients without TB infection. This study aimed to examine the genetic variation in TLRs (TLR2, TLR4, and TLR9) between patients with HIV-1 infection and those who progressed to active TB during the two years of follow-up. Results: During the two year follow-up of 373 positive patients, 98 patients progressed to active TB/AIDS (acquired immunodeficiency syndrome). When comparing 98 HIV patients who developed active TB/AIDS to 275 HIV patients who did not, it was discovered that the frequency of the A allele in TLR9 was considerably higher ( p < 0.001) in HIV patients progressed to active TB/AIDS. Ninety eight HIV individuals who advanced to active TB/AIDS showed a significantly higher frequency of the AA genotype in TLR9 than did in HIV patients who had no TB/AIDS (p < 0.001). Conclusion: The increased association of the AA genotype of TLR9 in HIV patients who progressed to active TB during follow-up suggests that HIV-positive patients with the AA genotype of TLR9 have increased susceptibility towards TB during the disease progression. Keywords: toll-like receptors, human immunodeficiency virus, tuberculosis, acquired immunodeficiency syndrome, immune system An estimated 4197 people died of acquired immunodeficiency syndrome (AIDS) in India in 2021. The Annual New Infection (ANI) count in India is estimated at 6297 in 2021. 1,2 Tuberculosis (TB) remains one of the deadliest communicable diseases in the world. 3 It has been demonstrated that human immunodeficiency virus (HIV) positive subjects to exhibit variable susceptibility to TB infection and disease. 4,5 To reduce the mortality and morbidity associated with HIV-TB co-infection or avert TB development among HIV-positive patients, it is important to investigate the factors responsible for generating this inter-individual variability among HIV-positive hosts for TB infection. Studies have demonstrated a significant correlation between the elements of the immune system, susceptibility to various infections, and disease progression. It is well known that the host immune response contributes to host–pathogen interaction/host–virus crosstalk. 6,7 A genetic mutation, also known as genetic polymorphism, is defined as a change in the nucleotide sequence at a specific locus of the genome that occurs among individuals, groups, or populations. The most common genetic polymorphism in humans is a single nucleotide polymorphism (SNP), which arises from nucleotide base substitutions between purines (A, G) or between pyrimidines (C, T). Detailed analysis of human deoxyribonucleic acid (DNA) revealed that SNPs are primarily concentrated in specific regions of the genome, which encode proteins involved in host defense mechanisms, compared with other genes encoding body proteins/enzymes. The occurrence of genetic polymorphisms or variations in the DNA sequence confers variability in susceptibility to various infectious diseases. 8,9 Numerous studies have shown that the innate immune response is crucial for the etiology, progression, and susceptibility to TB of HIV disease. 10–13 The key component of the innate immune system, toll-like receptors (TLRs), are responsible for activating the signaling pathway that regulates HIV replication and disease progression. 14 In other words, the latent and chronic stages of HIV infection are dependent on TLR-mediated pathways. 15 Increasing evidence has indicated that mutations in TLRs and their associated signal transduction molecules may impair or modulate a host's ability to respond to pathogens. 16 It has b -Abstract Truncated-

Genetic variation of the HIV-1 subtype C transmitted/founder viruses long terminal repeat elements and the impact on transcription activation potential and clinical disease outcomes

Intrapatient Evolutionary Dynamics in an Individual Infected with HIV-1 CRF01_AE Who Experienced Periods of Treatment Failure

Genotypic and phenotypic characterization of long terminal repeat sequences from long-term survivors of human immunodeficiency virus type 1 infection.

Infection by Diverse HIV-1 Subtypes Leads to Different Elevations in HERV-K Transcriptional Levels in Human T Cell Lines

Transcriptome Analysis of CD4 T Cells from HIV-infected Individuals Receiving ART with LLV Revealed Novel Transcription Factors Regulating HIV-1 Promoter Activity

Transcription of HIV-1 at sites of intact latent provirus integration

Generation and characterization of infectious molecular clones of transmitted/founder HIV-1 subtype C viruses

Intragenic proviral elements support transcription of defective HIV-1 proviruses

Reconciling founder variant multiplicity of HIV-1 infection with the rate of CD4 decline

Temporal relationship between V1V2 variation, macrophage replication, and coreceptor adaptation during HIV-1 disease progression

Single-cell transcriptional landscapes reveal HIV-1-driven aberrant host gene transcription as a potential therapeutic target

HIV-1 diversity in viral reservoirs obtained from circulating T-cell subsets during early ART and beyond

CCAAT enhancer binding protein and nuclear factor of activated T cells regulate HIV-1 LTR via a novel conserved downstream site in cells of the monocyte-macrophage lineage

Enhanced Transcriptional Strength of HIV-1 Subtype C Minimizes Gene Expression Noise and Confers Stability to the Viral Latent State

T cell stimulation remodels the latently HIV-1 infected cell population by differential activation of proviral chromatin

Altered differentiation is central to HIV-specific CD4+ T cell dysfunction in progressive disease

Effect of transcription inhibition and generation of suppressive viral non-coding RNAs

Genetic Variance in the HIV-1 Founder Virus Vpr Affects Its Ability to Induce Cell Cycle G₂arrest and Cell Apoptosis.

Genetic Variation in Toll-Like Receptors (TLRs) 2, 4, and 9 Influences HIV Disease Progression Toward Active TB and AIDS

Differences in HIV-1 reservoir size, landscape characteristics and decay dynamics in acute and chronic treated HIV-1 Clade C infection

Cognate Antigen Engagement Induces HIV-1 Expression In CD4 T Cells From People On Long-Term ART